Published in Infect Immun on August 01, 1979
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32
Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99
Evaluation of virulence factor testing and characteristics of pathogenicity in Yersinia enterocolitica. Infect Immun (1983) 1.76
Nucleotide sequence of yst, the Yersinia enterocolitica gene encoding the heat-stable enterotoxin, and prevalence of the gene among pathogenic and nonpathogenic yersiniae. Infect Immun (1990) 1.68
YplA is exported by the Ysc, Ysa, and flagellar type III secretion systems of Yersinia enterocolitica. J Bacteriol (2002) 1.59
Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59
Transcription of the mutL repair, miaA tRNA modification, hfq pleiotropic regulator, and hflA region protease genes of Escherichia coli K-12 from clustered Esigma32-specific promoters during heat shock. J Bacteriol (1996) 1.39
Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica. J Bacteriol (1998) 1.35
MyfF, an element of the network regulating the synthesis of fibrillae in Yersinia enterocolitica. J Bacteriol (1995) 1.22
Role of Yersinia enterocolitica Yst toxin in experimental infection of young rabbits. Infect Immun (1992) 1.16
Effects of heat-stable enterotoxin of Yersinia enterocolitica on ion transport and cyclic guanosine 3',5'-monophosphate metabolism in rabbit ileum. Infect Immun (1979) 1.08
An enterotoxin-negative strain of Yersinia enterocolitica serotype O:3 is capable of producing diarrhea in mice. Infect Immun (1981) 1.06
Nutritional requirements for synthesis of heat-stable enterotoxin by Yersinia enterocolitica. Appl Environ Microbiol (1993) 0.98
Assessment of enterotoxin production by Yersinia enterocolitica and identification of a novel heat-stable enterotoxin produced by a noninvasive Y. enterocolitica strain isolated from clinical material. Infect Immun (1993) 0.95
Transcriptional analysis of long-term adaptation of Yersinia enterocolitica to low-temperature growth. J Bacteriol (2006) 0.94
Enterotoxin production and thermal resistance of Yersinia enterocolitica in milk. Appl Environ Microbiol (1980) 0.92
Further purification and characterization of heat-stable enterotoxin produced by Yersinia enterocolitica. Infect Immun (1982) 0.88
Production of enterotoxin by Yersinia bercovieri, a recently identified Yersinia enterocolitica-like species. Infect Immun (1999) 0.85
Detection of Yersinia enterocolitica heat-stable enterotoxin by suckling mouse bioassay. J Clin Microbiol (1981) 0.84
The pathogenicity of Yersinia enterocolitica strains isolated from various sources in four test systems. Can J Comp Med (1982) 0.82
Factors affecting detection of Yersinia enterocolitica heat-stable enterotoxin by the infant mouse test. J Clin Microbiol (1983) 0.78
Enterotoxin production in milk at 22 and 4 degrees C by Escherichia coli and Yersinia enterocolitica. Appl Environ Microbiol (1982) 0.76
Genetic Diversity among Yersinia enterocolitica Isolated from Chicken and Fish in and around Coimbatore City, India. Iran J Public Health (2014) 0.75
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. J Infect Dis (1972) 24.30
Experimental shigella keratoconjunctivitis; a preliminary report. Acta Microbiol Acad Sci Hung (1955) 11.91
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med (1978) 5.39
Biological evaluation of a methanol-soluble, heat-stable Escherichia coli enterotoxin in infant mice, pigs, rabbits, and calves. Infect Immun (1978) 4.45
Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94
Studies on the pathogenicity of Yersinia enterocolitica. I. Experimental infection in rabbits. Microbiol Immunol (1977) 2.99
Heat-stable Escherichia coli enterotoxin production in vivo. Infect Immun (1975) 2.52
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49
Enterotoxic activity of filtrates of escherichia coli in young pigs. Am J Vet Res (1968) 2.35
Characterization of a partially purified methanol-soluble heat-stable Escherichia coli enterotoxin in infant mice. Infect Immun (1978) 1.63
Effects of age and ambient temperature on the responses of infant mice to heat-stable enterotoxin of Escherichia coli: assay modifications. Infect Immun (1978) 1.36
Repression of heat-stable enterotoxin synthesis in enterotoxigenic Escherichia coli. Infect Immun (1977) 1.36
Heat-stable enterotoxin from Escherichia coli: factors involved in growth and toxin production. Infect Immun (1978) 0.97
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun (1975) 14.65
Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect Immun (1977) 10.84
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun (1978) 8.52
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nat New Biol (1972) 6.65
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med (1975) 5.20
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun (1979) 4.24
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) (1969) 4.20
Identification of enterotoxigenic Escherichia coli and serum antitoxin activity by the vascular permeability factor assay. Infect Immun (1973) 4.07
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis. Infect Immun (1977) 3.57
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
The histology of tendon attachments to bone in man. J Anat (1986) 3.17
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet (1992) 3.13
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Hemagglutination typing of Escherichia coli: definition of seven hemagglutination types. J Clin Microbiol (1980) 3.03
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1982) 2.88
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J Clin Microbiol (1981) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect (2010) 2.77
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med (1982) 2.71
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis (1999) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci (1991) 2.63
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control (1981) 2.43
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol (1990) 2.43
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet (1999) 2.41
Location of gene for Gorlin syndrome. Lancet (1992) 2.41
Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene (2001) 2.36
Airborne spread of brucellosis. Ann N Y Acad Sci (1980) 2.33
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res (1997) 2.27
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med (1982) 2.27
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother (1983) 2.20
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
Li-Fraumeni syndrome--a molecular and clinical review. Br J Cancer (1997) 2.14
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet (2009) 2.05
Mastectomies of healthy, contralateral breasts in patients with breast cancer. Br J Hosp Med (Lond) (2013) 2.00
Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med (1991) 1.97
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Detection of enteric viruses in treated drinking water. Appl Environ Microbiol (1984) 1.87
Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin. Infect Immun (1970) 1.87
Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob Agents Chemother (2000) 1.84
Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82
Occurrence of Giardia lamblia in children in day care centers. J Pediatr (1984) 1.82
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas. J Clin Microbiol (1992) 1.80
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA (1998) 1.77
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75